These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3084143)

  • 21. Induction and kinetics of natural killer cells in humans following interferon therapy.
    Huddlestone JR; Merigan TC; Oldstone MB
    Nature; 1979 Nov; 282(5737):417-9. PubMed ID: 503223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic and interferon-augmented natural killer (NK) cell activity in psoriasis.
    Jansén CT; Viander M
    Acta Derm Venereol; 1983; 63(5):384-7. PubMed ID: 6197835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of susceptibility to natural killer cells' cytotoxicity and regulation of HLA synthesis: differing efficacies of alpha, beta, and gamma interferons.
    Wallach D
    J Interferon Res; 1982; 2(3):329-38. PubMed ID: 6182251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers. Effect of monocytes.
    Platsoucas CD; Fernandes G; Good RA; Gupta S
    Int Arch Allergy Appl Immunol; 1986; 79(1):1-7. PubMed ID: 3079737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of long-term cyclosporine therapy on natural killer cell activity.
    Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential effects of recombinant interferons alpha, beta, and gamma on induction of human lymphokine (IL-2)-activated killer activity.
    Sone S; Utsugi T; Nii A; Ogura T
    J Natl Cancer Inst; 1988 May; 80(6):425-31. PubMed ID: 3130488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
    Cordero OJ; Sarandeses CS; López JL; Nogueira M
    Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective effect of interferon against natural killing activity is not mediated via the expression of class I MHC antigens.
    Reiter Z; Fischer DG; Rubinstein M
    Immunol Lett; 1988 Apr; 17(4):323-8. PubMed ID: 2453457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK; Djeu JY
    J Immunol; 1988 Dec; 141(11):4067-73. PubMed ID: 2460557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
    Platsoucas CD; Oleszak EL; Good RA
    Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells.
    Ortaldo JR; Mason A; Rehberg E; Moschera J; Kelder B; Pestka S; Herberman RB
    J Biol Chem; 1983 Dec; 258(24):15011-5. PubMed ID: 6654900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma.
    Wallach D
    Cell Immunol; 1983 Feb; 75(2):390-5. PubMed ID: 6403252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
    Hirai N; Hill NO; Motoo Y; Osther K
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine reversibly inhibits natural killer-cell activity.
    Citterio F; Cauda R; Tumbarello M; Pozzetto U; Ortona L; Castagneto M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):976-7. PubMed ID: 1989350
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro enhancement of natural killer cell activity against herpesvirus-infected targets in patients with acute lymphocytic leukemia.
    McKolanis JR; Ragab AH; Schmid DS
    Arch Virol; 1991; 117(1-2):17-28. PubMed ID: 1848749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of interferon alpha and gamma, singly or in combination on human natural cell mediated cytotoxicity.
    Rawlinson L; Dalton BJ; Rogers K; Rees RC
    Biosci Rep; 1989 Oct; 9(5):549-57. PubMed ID: 2508783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the natural killer cell response to interferon-alpha by biogenic amines.
    Hellstrand K; Kylefjord H; Asea A; Hermodsson S
    J Interferon Res; 1992 Jun; 12(3):199-206. PubMed ID: 1640122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study.
    Radice E; Miranda V; Bellone G
    Int Immunopharmacol; 2014 Mar; 19(1):66-73. PubMed ID: 24369312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.